← Study Library
Animal · 2022 · n=48
Preclinicalcounts toward this tierImprovement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol
Bai LB, Yau LF, Tong TT, Chan WH, Zhang W, Jiang ZH · Pharmacology Research & Perspectives
Preclinicalcounts toward this tier
The only direct test of the NMN-plus-resveratrol pairing found: in healthy mice the combination raised NAD+ 1.59-fold in heart and 1.72-fold in skeletal muscle compared with NMN alone (both p<0.001). Joint tissue was not among the six tissues measured.
- Population
- Healthy young male mice; NAD+ measured in brain, heart, kidney, liver, lung and muscle
- Intervention
- A single oral dose of NMN 500 mg/kg plus resveratrol 50 mg/kg (or ginsenosides Rh2&Rg3), sampled at 1, 2, 4 and 6 hours
- Comparator
- Oral NMN alone
- Limitations
- One oral dose followed for six hours in three animals per group per timepoint; the authors name that sample size as a limit on their own statistics. Healthy young mice, no disease model, no functional endpoint, and nothing measured in cartilage or any joint. The mechanism the authors propose for the combination is labelled speculation in the paper.
Cited by
2 entries reference this study
- NMN / NAD+ precursorsPRECL.
Supplements → Vitamins & cofactors
Evidence for that entry
Preclinical - ResveratrolNOT SUPP.
Supplements → Anti-inflammatories
Evidence for that entry
Not supported